1. Please check and comment entries here.
Table of Contents

    Topic review

    Sound Vibration on Human Health

    View times: 13
    Submitted by: Abdullah Mosabbir

    Definition

    This entry presents a narrative review of research literature to “map the landscape” of the mechanisms of the effect of sound vibration on humans including the physiological, neurological, and biochemical. It begins by narrowing music to sound and sound to vibration. The focus is on low frequency sound (up to 250 Hz) including infrasound (1–16 Hz). Types of application are described and include whole body vibration, vibroacoustics, and focal applications of vibration. Literature on mechanisms of response to vibration is categorized into hemodynamic, neurological, and musculoskeletal. Basic mechanisms of hemodynamic effects including stimulation of endothelial cells and vibropercussion; of neurological effects including protein kinases activation, nerve stimulation with a specific look at vibratory analgesia, and oscillatory coherence; of musculoskeletal effects including muscle stretch reflex, bone cell progenitor fate, vibration effects on bone ossification and resorption, and anabolic effects on spine and intervertebral discs. In every category research on clinical applications are described. The conclusion points to the complexity of the field of vibrational medicine and calls for specific comparative research on type of vibration delivery, amount of body or surface being stimulated, effect of specific frequencies and intensities to specific mechanisms, and to greater interdisciplinary cooperation and focus. 

    1. Introduction

    Music has the power to affect our health and wellbeing. This belief and related cultural practice has been evident throughout history [1][2], but the clinical profession of music therapy is only some 75 years old. As a field of practice music therapy has been described as an art and a science and regards to science its research foundation has drawn on psychoanalytic, humanistic, and behavioral traditions [3]. As an emergent practice within the healthcare context, the focus of music therapy (a therapeutic relationship employing music as a means) and music medicine (the music or sound itself as the therapeutic) research has been primarily evidence-based. Mechanisms of effect have received little attention until recently. To develop clinical and scientific legitimacy in general healthcare and expand its use as standard of care, research on the use of music must show both that it works (evidence-based research) and why it works (mechanism-based research).
    Part of the problem of creating a scientific foundation for music effects in healthcare is that music is a very complex phenomenon; to control its parameters scientifically is practically impossible. That is, if music is approached as “music”—a cognitively constructed product of a culturally situated acoustic phenomena—the variables that can affect a response are practically limitless. Efforts to provide more detailed reporting of the music used in research are a start [4]. However, another approach is to define the potential level of the response mechanism.

    1.1. Basic Concepts

    1.1.1. Mechanism

    Focusing on the mechanism itself can be highly complex. Craver and Bechtel [5] describe four dimensions of mechanisms: (1) a phenomenal dimension—a mechanism does things. For music the human ear offers a basic mechanism illustration. The ear translates compression and decompression of air molecules into the conscious perception of sound. (2) A componential dimension—a mechanism has components. In a simplified description the ear has components including the ear drum, the malleus, incus, stapes, and cochlea that transmit the vibration to the cilia which translate the physical vibration to an electrical signal for the auditory nerve. (3) A causal dimension—components interact to make the phenomenon happen. The components of the ear turn the air compressions into electrical signals transmitted through the auditory nerve to the internal perceptual processing system (a complex mechanism in itself). (4) An organizational dimension—components are organized in space and time. There is a particular organization of the components of the ear and how they interact that causes vibration to be perceived as sound.
    The basic question of what are the mechanisms of how people enjoy music illustrates a very important aspect of the challenge of studying mechanisms—the ear is essential in the perception of music but it is only a start to the understanding of the cascade of mechanisms or causes of music enjoyment. That understanding would involve further definition of the auditory nuclei in the brainstem, the role and function of the thalamus, the means of transmission to the auditory cortex, the role of memory in the perceptual process, the interaction of expectation with neurotransmitters like dopamine and their role in the perceived response, and so on. Similarly, the question of how does low frequency sound stimulates blood circulation leads to an examination of endothelial cell response resulting in nitric oxide release and its effect on blood flow and so on.
    The crucial point here, and an important caveat for this paper, is that research into the mechanisms of the effect of music on health is nascent and in most cases focused on the most obvious components of what can be presumed to be a complex system [6][7]. This paper will, therefore, attempt to point in the direction of potential mechanisms that appear to be emerging for further study rather than serve as a detailed explication of a set of defined mechanisms.

    1.1.2. Types of Stimulus and Response

    A starting point to study mechanisms is to try to categorize by type of stimulus and type of response. One of the difficult pivots in the thinking of many health researchers is to differentiate between “music” and “sound vibration” as the stimulus. The bulk of research by cognitive neuroscientists focuses on “music” and often with little control of the parameters of that music since the assumption is that the effect stems only from the cognitive processing of that music [8][9].
    Within the broad category of “music” as stimulus, the response focus can be on the general effects like arousal, mood, emotion, relaxation, stress, etc., and with the assumption that these responses result from enjoyment or aversion reactions, memory associations, or some inherent neurological process [8]. All of these responses can be attributed to learned schemas, processes, and associations developed through socially mediated cultural immersion from the very earliest days of exposure to music [10].
    A second category of mechanisms within “music” is to look at the effect of music cognition on the activation of neural circuits and specific neural functions. This has been most clearly defined in relation to rehabilitation [11][12].
    When music or audible sound is considered for its vibratory (rhythmicity) effects, a third category of response mechanism emerges and its focus becomes primarily cellular [10]. The most basic and oldest use of vibratory effect is the mechanical “shaking” of the body and more recently specific areas and cells. Another more specific category of cellular response is the effect of driving a neural modulatory response. The importance of rhythmic brain activity, and the potential for sensory stimulation to drive it, has not received much attention until recently [13][14]. However, for music as a vibratory phenomenon this is an important mechanism to study.

    1.1.3. Vibratory Rhythmicity

    Fundamental to vibratory effects is the rhythmicity of music. It can be thought of as events per second and seconds per event [15]. When there are more than 16 events per second cognitive event fusion changes from individual event perception to hearing pitch frequencies. The rhythmic stimulation effect on cells, however, continues to be related to the events per second even, for example, at 40 or 60 events per second (Hz). If the events are slower than about 10 s per event, long-term memory may allow perception as functional units of musical form but these will not be heard as individual events. Body rhythm cycles, like the 10 s baroreceptor control loop, may still be response to entrainment by recurring events at this frequency and influence these Mayer waves to release endothelial derived nitric oxide [16]. Between 16 events per second and 10 s per event lies the area where short-term memory allows cognitive perception of the individual events as notes, patterns, or melodic groupings. In this category people align physical movement like running, walking, dancing, foot or finger tapping, or mental tracking with the beat. This category of cognitively tracked rhythmicity has known effects of neural, cardiac, and breath entrainment and is used therapeutically, for example, in rhythmic auditory stimulation (RAS) [11]. However, it also has direct effects on cells through mechanical movement.
    This paper will not focus on music as “music”; it will focus exclusively on the rhythmicity of music and sound as vibration. In many cases the focus is on the effect of single frequencies although these frequencies may be imbedded in music and heard by the recipient simply as music.

    1.2. Vibratory Applications to Health

    1.2.1. Historic Predicates

    It is common to encounter studies of the effect of vibration and low frequency sound in industrial-oriented research. These studies typically focus on the potentially negative effects of specific work environments, use of particular equipment, and primarily exposure to low frequency vibration and noise [17][18]. However, there is also a long history of interest in the positive effects of vibration. Carriage rides on rough cobblestones came to be associated with positive health effects and mechanical “chairs” emulating these rides were created. In the 18th century the Abbéde St. Pierre created the tré moussoir or fauteuil de poste as a vibrating chair to help patients with melancholia, liver disease, and other conditions that seemed to respond to carriage rides [19]. The 19th century saw considerable interest in vibration and the development of vibrating tools including the chair created by Dr. Jégu after seeing Parkinson’s disease (PD) symptoms calmed by a carriage ride [19][20]. Dr. Jean-Martin Charcot, the most noted neurologist of that century, began studying PD with the chair but acknowledged an earlier physician, M. Vigoroux, who in 1878 used a sounding box with a very large attached tuning fork played with a bow to successfully treat patients with hemianesthesia and locomotor ataxia [21]. Charcot also described treatment of neuraglia and migraines by Dr. Boudet of Paris with tuning forks mounted on small boards. Gilles de la Tourette, Charcot’s assistant, applied the idea of vibration therapy to the brain [19][20][21] with a metal helmet he devised with a motor on top causing the helmet to vibrate at 10Hz. It was found to have a positive effect on insomnia, migraines, and depression and other vague conditions [21].

    1.2.2. Current Therapeutic Application Concepts for Vibration

    Whole body vibration (WBV), also referred to as whole body periodic acceleration (WBPA) is one type of application that grew out of the 18th and 19th century interest in vibration. WBV, a mechanical vibration typically created with stand-on oscillating platforms, developed largely in response to concerns about the effect of weightlessness in space on bone and muscle and then was quickly applied in sports [22]. Although current WBV platforms can produce vibration frequencies up to 100 Hz, frequencies below 30 Hz are most commonly used. The past 20 years has seen growing interest in the effects of WBV on bone density, orthopaedic, and neurological concerns [23][24].
    More in keeping with the early uses of tuning forks for sensory stimulation is the practice of low frequency sound therapy (and most closely related to music therapy) that has developed in the past 50 years and is now commonly known as vibroacoustic therapy (VAT). WBV typically uses frequencies below 30 Hz while VAT uses 30–120 Hz. Olav Skille in Norway and Petri Lehikoinen in Finland were the leaders in this use of sinusoidal sound to stimulate the body for therapeutic purposes. Skille placed particular emphasis on single pitches at 40, 52, 68, and 86 Hz modulated with a steady rise and fall of amplitude at a rate of about 6.8 s from peak to peak. A noteworthy application of this method in research was done by Wigram [25][26]. Instead of single frequencies, Lehikoinen used constant frequency scanning with the intent to treat muscles at their particular resonance frequency, slow power pulsation to prevent muscle contraction, and at times directional movement of the sound [27]. Lehikoinen developed the NextWave chair system that was Federal Drug Administration (FDA) and British Standards Institution (BSI) approved in 1996 for three claims related to physioacoustic therapy: increased blood and lymphatic circulation, decreased pain and stress, and increased muscle relaxation and mobility [28]. Numerous devices that include chairs, chair backs, beds, mats, pillows, backpacks, and smaller hand-held units have been developed since then.

    1.3. Definitions, Clarifications, and Terminology

    1.3.1. Source of Pulsed Stimulation: Sound Waves or Mechanical Compression

    To review the literature related to vibration, one of the fundamental questions requiring clarification is whether the stimulation of the body with sound waves is different in some way from mechanical vibration. Since people hear sound waves and feel mechanical vibrations, an easy conclusion is that the two are categorically different. However, sound in essence is mechanical vibration that transmits through a medium [29]. In the medium of air, the sound actuator creates a vibration that results in regular compressions and decompressions of air molecules that travel to the receiving surface on the body such as the ear’s tympanic membrane or the mechanoreceptors in the skin. In water a rapidly oscillating membrane would create compressions and decompressions of water molecules. Once in contact with the body, the compression and decompression of the surface of the body is transmitted through bone and tissue and may be sensed by a set of mechanoreceptors or by our auditory system.
    At a cellular or molecular level in the body there is probably no difference between activation by air molecules applying regular sine wave pressure on the body, by a surface applying oscillatory pressure stemming from a rotating motor shaft, or by the body itself moving against gravity on an oscillating platform. Another way to understand this can be in comparing the application of sound to produce vibration and the application of vibration to produce sound. Sound, which propagates through a material can vibrate the material and be physically felt like a massage, such as in a vibroacoustic device [30]. Mechanical vibration can also produce sound. Bone conduction headphones are commercially available and are built to be positioned along the skull. The mechanical vibration of the bones of the skull propagate to the inner ear and are perceived as sound [31]. Therefore, the interchange of sound and mechanical vibration demonstrate that they are in essence the same thing.

    1.3.2. Vocabulary and Inclusion

    Clarification is needed about the vocabulary used in this field. We have already explained VAT and WBV. Another term used is rhythmic sensory stimulation (RSS) and is inclusive of multiple types of pulsed (rhythmic) stimulation. RSS includes whole body rhythmic movement, vibrotactile stimulation of all or part of the body, auditory pulses delivered as individual sound units (like hits on a drum, plucks of a string, interaction “waves” resulting from binaural detunement, or isochronous amplitude modulated sound trains) or as molecular compressions that create continuous sound (research usually focusing on low frequency sound 20–130 Hz), and visual light flashes or flicker. Pulsed ultrasound can also be regarded as a type of vibrational mechanical stimulation and is typically applied in 2 ms bursts but with varying ratios of sound to silence from 1:1 (250 Hz) to 1:20 (45 Hz).
    When considering the use of rhythmic pulses to stimulate to the body, one question is whether electric stimulation and pulsed ultrasound are comparable to mechanical vibration. Bartel et al. [32] drew parallels between pulsation frequencies used in electric stimulation and pulsed ultrasound with frequencies for VAT. Many years ago Charcot postulated that the vibration stimulation was not unlike electric stimulation and showed similar results [21]. In this paper the review of specific mechanisms activated by vibration will be restricted to studies using various sonic and mechanical vibratory means from general body vibration to focused points of vibration delivered with pencil-like probes. However, a future more extensive review of the mechanisms activated by pulsed stimulation might include electrical and pulsed ultrasound stimulation as well.
    A final question is whether whole body vibration (WBV) is fundamentally different from vibroacoustic therapy (VAT) and, therefore, WBV studies cannot be mixed with VAT in the examination of mechanisms. First, although many applications of WBV use frequencies in the level of infrasound (1–15 Hz) they also use higher frequencies (e.g., 20–40 Hz) in the same range that VAT frequently uses. Music stimulation and VAT can employ pulsed sound units at 1–15 Hz and, in fact, “rhythm” in music is primarily in that frequency. So, there is no set frequency that makes it one or the other. Secondly, the axis of the applied vibration may be a discriminator between approaches (e.g., vertical (axial), horizontal, or multidirectional) but at the mechanism level there does not appear to be strict differentiation. For example, with blood flow slow axial (direction of the spine) WBV creates pulsatile stress on endothelial cells and so enhances blood flow at 1 or 2 Hz [33] but also with sound stimulation at 50 Hz [34]. Rhythmic driving of oscillatory coherence happens with rhythmic pulses at 1 or 2 Hz (delta entrainment, e.g., RAS effects) and at 10 Hz (alpha), 20 Hz beta, or 40 Hz gamma, etc. Consequently, at the level of the mechanism, WBV and VAT will be considered within the same domain of pulsed stimulation.

    1.4. Methodology and Scope

    1.4.1. Narrative Review Approach

    In the next section we will present a narrative review of research literature that tries to map the basic “lay of the land” of vibration stimulated mechanisms and what health conditions may be affected. This is not a systematic critical review of research methodology, but rather a “cataloguing” effort to describe applications of vibration and mechanisms of effect. This effort was motivated by the perception that this has not been done to date. Researchers working on the mechanisms of vibration effect have essentially worked in silos. We determined to look for commonalities among the silos by looking not at the vibratory device, frequency, or context of application, but rather at mechanisms involved. Consequently, our search for studies to include was an emergent process from general to specific with the intent to identify categories of mechanism and then the specifics within the categories. We used a basic strategy to locate candidate studies: an electronic database search including PubMed, Scopus, and Google Scholar. Initial searches included terms such as “Vibration and Health”, “Vibration mechanism”, and “Vibration treatments” from years 1975 to 2021. We filtered based on number of citations and considered the more cited work first. After an initial collection of literature and, as researchers starting with the greatest awareness of VAT where the 1996 FDA claims for blood circulation, pain reduction (neurological), and mobility (musculoskeletal) effects were established, we decided to focus on three central concepts of vibration mechanisms for further searches: the effects of vibration on the blood, the nerves/brain, and bone/muscle. A further refined search included terms like “vibration and blood mechanism”, “vibration and neuron mechanism”, “vibration and brain”, “vibration and bone/muscle mechanism”, etc., followed by specific mechanism like endothelial stimulation or mechanoreceptor response. The identification and selection of papers was driven primarily by an attempt to describe the “field”, the “lay of the land” of vibration research. Further, our focus was closely held to mechanism and not evidence-based clinical research related to vibration without attention to mechanism. Papers were chosen based on whether we believed them to add to our understanding of the effects of vibration on health via those areas.

    1.4.2. Mechanisms of Response to Vibration

    The auditory and vibrotactile stimulation from low frequency sound shows effects that are essentially the result of two categories of mechanisms: (1) physical, through muscular and cellular means, and (2) neurological, through sensory-based stimulation of nerves and receptors. At the physical level sound vibration is sensed by tactile receptors in the outer skin (Merkel disks—sensing vibratory strength and responding most to 5–15 Hz), inner skin (Meisner corpuscles—sensing vibratory frequency and responding most to 20–50 Hz), and in deeper tissues (Pacinian corpuscles—sensing acceleration and responding most to 60–400 Hz) [35][36]. To avoid numbing of these sensors, VAT is usually constantly varied in amplitude (power pulsation) and/or frequency (scanning). A physical therapeutic effect can be obtained at a cellular and lymphatic level due to increased fluid and cellular waste transport, increased cellular metabolism [37][38], increased blood circulation, and muscular relaxation due to a resonance response. Within the brain, vibration hypothetically enhances flow of cerebrospinal fluid and speeds removal of metabolic waste [39]. Most research with VAT has not explored neural oscillatory effects but recent studies show [40][41][42][43][44] potential brain effects, especially through prolonged application of a single frequency (e.g., 40 Hz).
    In 1996 the Federal Drug Administration (FDA) reviewed the Next Wave Physioacoustic Chair designed for medical purposes with six imbedded subwoofer speakers used to apply low frequency sound vibration to the body from knees to shoulders at frequencies from 20 to 130 Hz. The FDA approved three claims for the treatment at the time called physioacoustic therapy [28]: (1) increased blood circulation, (2) decreased pain, and (3) increased mobility. Although no evidence was provided at the time for mechanisms of action, the three areas generally pointed to hemodynamic effects, to neurological effects, and to musculoskeletal effects. This FDA approval is important and noteworthy because it appears to be the earliest vibration device approved for multiple claims. Although whole body vibration (WBV) devices have been used for many years with the intent of developing bone and muscle strength, FDA approval was not granted [45]. More recently specific limited application devices using vibration have been cleared for sale [46][47]. However, the effects claimed for WBV and the recent devices fit into the original categories of claim from 1996. Further the general broad categories for the claims for physioacoustic therapy encompass the vast majority of mechanisms we discovered in the literature. The exceptions were primarily in the effects of mechanical shaking related to phlegm and mucous [48] or orthodontics [49].

    1.5. Organization of the Analysis of Mechanisms

    In the following three sections we explicate three primary categories of mechanisms activated by vibration applied to the body: hemodynamic, neurological, and musculoskeletal. By using the concept of mechanism established by Craver and Bechtel [5] we consider the causal and organizational dimensions to identify what we call basic mechanisms and submechanisms. This is a utilitarian simplification to focus, what is in most cases a complex system, on the organizational sequence. For example, vibration results in stimulation of endothelial cells (basic or first step mechanism), which then in turn releases nitric oxide and adrenomedullin, which have different effects and so are designated submechanisms. As we have stated earlier, this will not be an exhaustive and definitive description of complex chains of mechanistic actions. Rather we are setting out to point to directions for further research investigations of the effects of vibration on the body. In addition to identifying basic causal mechanisms, we describe some health related applications. Not every mechanism described in research has clear clinical applications. This is a nascent field where much more research is required and where knowledge translation into clinical application is needed.

    2. Hemodynamic Effects

    2.1. Basic Mechanism: Stimulation of Endothelial Cells

    2.1.1. Submechanism: Nitric Oxide

    One of the effects of vibration applied to the body acknowledged by the FDA in 1996 was an increase in blood circulation [28]. The question is by what mechanism does vibration affect blood flow. A crucial signaling molecule that has a pivotal role in regulating blood flow and oxygenation of tissues is nitric oxide (NO). Nitric oxide is produced and released into the blood by the endothelial cells that line the blood vessels and lymphatic vessels. Vibration stimulates the endothelial cells to produce and release NO in several forms of which the isoform endothelial nitric oxide synthase (eNOS) is of particular importance for the generation of NO from endothelial cells. Although the detailed mechanisms of how sound affects the mechanosensors in the endothelium to control eNOS is not yet completely understood, it appears that the endothelial cells mechanosensor-proteins, Syndecan-4 (Syn4) vascular endothelial growth factor (VEGF), and Krüppel-like Factor 2 (KLF2) translate the physical force from the vibration into biochemical signals. Studies have shown that vibroacoustic stimulation can induce Syn4 and VEGF [50][51]. NO regulates blood flow and vascular tone by affecting the vascular smooth muscle with the activation of the enzyme guanylate cyclase (sGC) [52] and the phosphorylation of extracellular signal-regulated kinase (ERK1/2) [53]. Although the purpose of stimulation, mode of vibration delivery, and frequency of vibration varies, endothelial cell stimulation releases NO and induces blood flow. The effect has been observed with whole body periodic acceleration using a platform (pGz) at 2 Hz [54], with microcirculation in the skin at 47 Hz [55], externally applied vibration to the arm at 50 Hz [34], sonic vibration applied to the chest at 100 Hz [56], and at various body surfaces at 150–250 Hz [57].

    Application: General Blood Flow

    Since vibrational stimulation induces blood flow, this may find general application to conditions resulting in decreased blood flow like diabetes. Maloney-Hinds [34] used 50 Hz vibrational stimuli for five minutes on participants’ forearms and found NO production increased by 374% in the healthy controls and by 236% in the diabetes group. Skin blood flow was significantly increased (p = 0.0001) in both groups. Johnson et al. [58] studied diabetes patients with whole body vibration at 26 Hz and also found significant increase (p = 0.01) in skin blood flow but with less effect than Maloney-Hinds using direct to skin vibration.

    Application: Cardio Protection and Therapy

    An approach to stimulation of endothelial cells is “periodic acceleration” (pGz) consisting of repetitively moving the body in a head-to-foot direction at a typical rate between 1–3 Hz resulting in an increase in “pulsatile shear stress” on the endothelium—the friction of the blood against the endothelial lining of blood vessels resulting from the “pulse” of the movement and the gravitational force on the blood. This “shear stress” of the blood against the lining stimulates the release of NO and other endothelial-derived cytoprotective factors.
    One application of pGz is as a form of cardiopulmonary resuscitation (CPR) where the body is moved head to foot at a rate similar to standard compression CPR. Adams et al. [59], in an animal study, found pGz as effective as standard CPR in terms of resuscitation survival rate and other acute outcomes but with fewer rib fractures.
    An animal study by Adams et al. [60] applied pGz at 3 Hz for 30 min after induced cardiac arrest and resuscitation. The animals receiving the pGz treatment had a smaller reduction in the function of heart contraction (myocardial stunning), greater flow of blood to the heart, kidneys, stomach, and brain, showed less of an increase in Troponin I, a protein released into the blood stream indicating damage to the heart muscles, and a greater increase in eNOS.
    The previous two studies by Adams et al. [61] used endothelial stimulation as a post-cardiac arrest treatment. Does it also offer preventative protection? They examined this by studying the occurrence of tissue damage caused by a return of oxygen rich blood following a period of oxygen deprivation (ischemia-reperfusion injury) caused by ventricular fibrillation (VF). Animal subjects were given one hour of pGz stimulation at 3 Hz prior to the induced VF. The animals receiving the stimulation had fewer arrhythmias of the blood circulation pulse, less myocardial stunning, stronger regional blood flow to organs of the body, and less indication of heart damage (Troponin I). Tests showed that the animals receiving the pulsed stimulation at 3 Hz had higher levels of endothelial nitric oxide with the conclusion that elevation of eNOS may have a cardioprotective function.
    The studies by Adams reported above focus on heart function and effects where blood volume is constant. Bassuk et al. [62] looked at the effect of one hour of pulsed stimulation (pGz at 3 Hz) before and during significant blood loss from hemorrhage. The results showed significantly less oxygen consumption in the treatment group at all points of the hemorrhage and, after 40 mL/kg of blood loss, better preservation of regional blood flow to stomach, ileum, kidneys, heart, and brain. The authors attribute this effect to the shear stress produced by the motion on the endothelium and the release of nitric oxide.

    Application: Neuroprotection and Neurotherapy

    Aerobic exercise and the pulsed stimulation of whole body periodic acceleration (WBPA), also known as pGz, both have been shown to have positive cardiovascular effects through activation of nitric oxide (NO). In addition, the NO effect is known to induce the brain derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF) thereby contributing a neuroprotective (prior to damaging events) and neurotherapeutic effect (following damaging events). A study by Adams et al. [33] showed that aerobic exercise significantly increases blood flow to the skeletal and heart muscles but not to the brain while WBPA increase blood flow with BDNF and GDNF to the brain and the heart but not to the muscles. They concluded that rhythmically pulsed stimulation of the endothelium can be a non-invasive strategy for neuroprotection and neurotherapy.
    In a more detailed examination of the effects of WBPA on the brains of mdx mice, Lopez et al. [63] found an overload of calcium and sodium ions and an overproduction of reactive oxygen species (ROS) in the neurons resulting in cognitive dysfunction. After WBPA for one hour per day for eight days at 8 Hz, results showed that the elevation of calcium and sodium ions and the overproduction of ROS had been mollified along with an increase in enzymes that protect cells. This study again demonstrated the efficacy of pulsed stimulation of the endothelium to release nitric oxide and a cascade of factors that result in neuroprotection and neurotherapy.

    2.1.2. Submechanism: Adrenomedullin

    In addition to the release of nitric oxide, the vibratory stimulation of endothelial cells has been shown to release the cell protecting mediator, adrenomedullin (AM). It may function as a hormone in controlling circulation and vasodilation but also serves to stimulate angiogenesis—the growth of new blood vessels—and combats oxidative stress in cells. In this way AM can have a positive effect in cardiovascular disease including hypertension, myocardial infarction, and chronic obstructive pulmonary disease. However, in its function to extend blood supply in cells it may be a negative factor in relation to cancer. Martínez et al. [64] conducted an animal study to examine the effect of one hour of pGz stimulation on AM and found that immediately after the stimulation blood pressure was significantly reduced (from 115 ± 10 to 90 ± 8) and AM level was significantly increased and remained so for 3 h (from 776 ± 176 pg/mL baseline to 1584 ± 160 pg/mL, p < 0.01).

    2.1.3. Submechanism: Antioxidants

    Many disease conditions are linked to oxidative stress. These include cancer, Alzheimer’s and Parkinson’s disease, diabetes, and cardiovascular conditions like high blood pressure, atherosclerosis, and stroke. Release of nitric oxide into circulation is known to have some antioxidant properties. Uryash et al. [65], in a study with mice with high oxidative stress, specifically looked for the effect of pGz on eNOS and antioxidants. The subjects were given pGz for an hour a day and tissue was tested after one, two, and four weeks. The pulsed stimulation resulted in significant expression of antioxidants including glutathioneperoxidase-1 (GPX-1), catalase (CAT), superoxide, and superoxide dismutase 1 (SOD1). It also decreased reactive oxygen species (ROS).

    2.2. Basic Mechanism: Vibropercussion

    One of the features of vibration is that it results in one material striking against another—whether molecule to molecule or cell to cell or bone to bone, etc. The essentially mechanical action can produce health-related effects.

    Application: Blood Clot Dissolution

    To study the effect of mechanically pulsating a blood clot Hoffman and Gill [66] conducted an in-vitro study (outside the body) placing a one-hour-old blood clot into a solution of the medication Heparin typically used as a blood thinner to treat heart attacks or angina. The vessel holding the blood clot was then vibrated at 50 Hz for 20 min with a very low amplitude to simulate the amount of vibration that might be transferred into the body from a surface vibration. The result showed significantly better clot dissolution with vibration (25%) versus no vibration (5%). Hoffman and Gill [67] then basically replicated the study but applying the vibration externally through a 4 cm slab of meat as simulation of human body structure and varying the vibration to 50 Hz applied in short bursts of one per second. In addition to Heparin, they did a sample with Streptokinase, a medication specifically designed to break down clots. They again found the vibration very significantly increased clot dissolution, and with greater effect in the Streptokinase group attributed to enhanced mixing and penetration (or in a sense “drug delivery”) of the lytic agent, which was originally disposed from the clot.
    One context where vibration is associated with stroke treatment is the “drip and ship” situation where a patient is started on a drip of recombinant tissue-type plasminogen activator (rtPA) and then transported to a hospital in a helicopter. The helicopter typically presents an unavoidable vibration in the range of 0.5–120 Hz. Researchers [68][69] have been concerned that the vibrating transport might have a negative effect on outcomes and so studied the effects finding that there is no negative effect. However, they did not consider that there might be a positive outcome and did not record the dominant vibration frequencies or control for them. Most recently Dhanesha et al. [70] did consider the possibility of a positive effect and noted vibration frequency, used a ground-based vibration simulation arm in the study along with the no vibration control and the actual helicopter flight. They found that the animals receiving the rtPA and the simulated vibration had significantly smaller infarctions (areas of tissue death from a blood clot) and increased positive neurological outcomes (86% vs. 28%). Oddly, the actual helicopter flight group did not have significantly positive outcomes which the researchers speculate could be due to the 20–30 Hz band of vibration was attenuated in this helicopter flight. Dhanesha et al. concluded that low frequency vibration is synergistic with rtPA and that application of vibration might be a safe and simple intervention for stroke.

    3. Neurological Effects

    Effects of sound vibration stimulation on the neurological system are many and wide-ranging with multiple complex mechanisms involved. Most of these mechanisms are not yet fully understood but we will point to how the mechanisms at a cellular level seem to function and are related to sound vibration.

    3.1. Basic Mechanism: Protein Kinases Activation

    One of the questions of neuroscience is whether there is a way to regenerate or repair neural damage from neurodegeneration, stroke, transected nerve ends, etc. Electrical stimulation [71] is one intervention that has shown some success in creating axonal regeneration and neurite outgrowth. Low frequency sound vibration also appears to have potential at stimulating neurite outgrowth and neuronal differentiation.
    Koike et al. [72], motivated by the intent to find why music therapy might be useful for Alzheimer’s disease (AD) patients, conducted a study to determine if vibratory sounds might enhance neurite outgrowth. They focused on an in-vitro examination of PC12m3 cells known to be sensitive to nerve growth factor (NGF) that induces differentiation of nerve cells and neurite extension. They looked specifically at the p38 mitogen-activated protein kinase (MAPK) activity that has been shown by research with electrical stimulation [71] to be a pathway to enhancing PC12m3 cell growth, and which also appears enhanced in AD. They found that vibratory sound in the 10–100 Hz range had a positive effect on neurite growth with the strongest effect being at 40 Hz whereas vibratory sound at 150 Hz and 200 Hz had little effect. They found that 40 Hz stimulation enhanced p38 MAPK activity indicating that the neural outgrowth they observed was induced through the p38 MAPK pathway.
    Cho et al. [73] and Kim et al. [74] examined the effect of 40 Hz sonic vibration on cell differentiation of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs). hUC-MSCs can differentiate into various types including neurons. Cho et al. applied vibration to the cells continuously for 5 days; Kim et al. for 3 or 5 days. Cho determined the differentiated cells were neuron-related oligodendrocytes because they expressed microtubule-associated protein 2 (MAP-2), which is a marker of synapse plasticity, glial fibrillary acidic protein (GFAP) thought to maintain astrocyte structure, and myelin basic protein (MBP) a component of myelin structure. Cho determined that the mechanism mediating the effect of vibration on the UC-MSCs was the extracellular-signal-regulated kinase (ERK) pathway. Kim et al. similarly examined protein expression related to neural differentiation stimulated by the 40 Hz vibration. They found that the protein calponin 3 (CNN3) promoted functional neural differentiation.
    Choi et al. [75] examined the effect of multiple frequencies of low frequency vibration on adipose tissue-derived stem cells (AT-MSCs). Adipose tissue is commonly referred to as body fat and AT-MSCs are among the most studied in recent research. Choi applied vibration to the AT-MSCs for four days at 10, 20, 30, and 40 Hz with specific focus on the mechanism of ERK. They found that 30 Hz was most effective at affecting neural differentiation of these specific stem cells.

    3.2. Basic Mechanism: Nerve Stimulation

    Evidenced-based research repeatedly shows positive clinical effects from the application of pulsed stimulation of the body. This applies in varied neurological conditions including cerebral palsy [76], multiple sclerosis [77], and chronic musculoskeletal pain [78]. The question is whether this results in some way from a stimulation of the nervous system and if so, how does that occur. How pervasive is a system to respond to vibration? In the living body transmission of sensory information depends on sensory neurons and mechanosensation at axonal terminals in peripheral nerves. Different types of sensing neurons include mechanosensors detecting external signals, proprioceptors receiving internal body signals, and many types of nociceptors that detect noxious body-threatening stimuli. Usoskina et al. [79] examined the molecular mechanisms activated in the process of cells detecting vibration. By observing calcium ion transients in the somata of neurons, they saw that neurons reliably detected every individual stimulus (e.g., each molecular compression in a sound wave) and then converted these into specific firing patterns in the nerves. Given this basic mechanism, we next look at several categories in which this is applied.

    3.2.1. Submechanism: Sensitization of the Proprioception System

    The body’s proprioception system gathers and processes information about changes in the position of joints and limbs and, therefore, is strongly involved in the control of posture and movement. Proprioceptors are mechanosensory neurons in the skin (Merkel disks and Meissner’s and Pacinian corpuscles), muscles (spindles), tendons (Golgi tendon organs), and joints. This proprioception system involving receptors, nerves, spinal cord, and pathways of the central nervous system terminates within the thalamus and cerebral cortex [36].
    The proprioception system is very sensitive to vibration and, since it is an important factor in motor control, the effect of vibration has been the subject of considerable research, especially the effect of whole body vibration on the rehabilitation of neurological disorders [80]. The stimulation or sensitization of the proprioception system appears to engage a mechanism that retrains the body-mind strategies of motor control or establishes greater consonance between input from the senses and output to the motor system at the cortical level [81]. Perhaps pointing to a cascade effect in this proprioceptive mechanism, which is not fully understood, Delecluse et al. [82] propose that vibration may enhance corticospinal cell connectivity to spinal motor neurons.

    Application: Complex Regional Pain Syndrome (CRPS)

    Gay et al. [81] postulated that CRPS type I may be caused by a sensory input–output mismatch that leads to motor programming disorganization in cortical structures. They hypothesized that enhancing proprioceptive feedback with vibratory stimulation would minimize pain and increase range of motion. The study by Gay et al. [81] applied sinusoidal vibration at 86 Hz to the hand and wrist of patients with CRPS for 20 min a day, five days a week for 10 weeks in addition to conventional rehabilitation sessions. The control group received only the conventional treatment. The results showed that pain severity was lower by close to 50% and range of motion improved by about 30% in the treatment group. They attributed this result to a reestablishment of sensory input–output consonance.

    Application: Cerebral Palsy

    The research of Katusic et al. [80] proceeded on the premise that proprioception is crucial to motor control and hypothesized that sound-based vibration can resonate through the body and enhance sensation of body position, location, and orientation. Further they accepted the premise of Delecluse et al. [82] that vibration could alter corticospinal cell and spinal motor neuron connectivity and that this stimulation of the proprioceptive pathways could rearrange motor control strategies resulting in better postural stability. To test this Katusic et al. [80] did a three month study with 89 children with spastic cerebral palsy (CP) randomized to a physiotherapy only group and to physiotherapy plus vibration group. The vibration treatment, applied with a mat they could lie on, consisted of 40 Hz sine waves for 20 min, two times a week for 12 weeks. The vibration treatment group improved significantly in both spasticity and in gross motor function.
    Ko et al. [83] observe that vibration has recently been shown to improve proprioception and thereby balance and motor skills. They postulate that this may be because vibration stimulates muscles and tendons. To test whether whole body vibration at 20–24 Hz would affect sense of joint position, gait, and balance in children with CP, they randomized 24 children to physical therapy (PT) or traditional PT plus vibration for 20 min (3 min on, 3 min off) two times a week for three weeks. They found significant improvement in joint position sense and improvement in gait variables in the vibration group.

    3.2.2. Submechanism: Vagal Nerve Stimulation

    The vagus nerve, one of the 12 cranial nerves, serves as a major parasympathetic (efferent) component of the autonomic nervous system and importantly transmits sensory information from much of the body to the brain [84]. It plays a key role in cardiac and gastrointestinal function, in muscle control of mouth and throat, in the neuroendocrine-immune system, and in the regulation of emotion including anxiety and depression. Vagus nerve stimulation (VNS) [84] is a recognized practice commonly done with manual massage or compression, electrical stimulation, or vibration including with the voice or gargling throat or with external vibrotactile devices. However, the spleen has nerve fibers that are integrated with the vagus nerve and studies [85][86] show that anti-inflammatory effects of the vagus nerve rely somewhat on the splenic nerve to the extent that stimulation of the splenic nerve results in immunosuppressive effects comparable to VNS [87]. Vibration at the abdominal level [88] may then be stimulating the splenic–vagal nerve system. Specific applications of VNS include refractory epilepsy, depression, and decreasing inflammation. One of the known mechanisms by which stimulation of the vagus nerve has its effect is the release of the neurotransmitter acetylcholine.

    Application: Depression

    Sigurdardóttir et al. [88] conducted a study with 38 people with depressive disorder (18 treatment, 20 control) using relaxing music with a specifically created low frequency sound track that activated a vibrotactile transducer at the abdominal level at the back of the chair in which they were seated. The premised mechanism for their intended effect was the activation of Pacinian corpuscles sending an afferent impulse in the vagus nerve to the regions of the brain associated with depression. The vibratory stimulation treatment was applied for 20 min in eight sessions over 3–4 weeks. The authors did not report what specific frequencies they employed but maintain that Pacinian corpuscles stimulated at 240 Hz have a maximal afferent output but afferent output occurs at any frequency below that. Although not a rigorously controlled study and not measuring changes in the vagal tone, the pilot study did find a reduction in depression scores in the treatment group and attributes this to stimulation of the vagus nerve and the central nervous system through the abdomen. A study by Braun Janzen et al. [89] that applied a very similar treatment also found a reduction in depression and anhedonia although it did not premise vagal stimulation.

    Application: Rett’s Syndrome

    Rett’s syndrome (RS) is a gene mutation-based neurological disorder mainly affecting females that involves brain stem immaturity [90] resulting in dysfunction of the autonomic nervous system. The resultant symptoms are numerous with many associations to the vagus nerve. These include breathing and cardiac function, speech and hearing-related communication, and movement control and seizures [91][92]. Vagus nerve stimulation has shown positive results in reducing epileptic seizures [91] and along with auditory stimulation has been effective in increasing cortical strength and auditory function [92].
    Bergström-Isacsson et al. [93] examined neurophysiological brainstem data and emotional response in 29 Rett’s participants and 11 controls to six stimuli with music and low frequency vibration at 40 Hz. Each stimulus was presented for 10 min in a repeated measures design. Outcome measures used were mean arterial blood pressure, the coefficient of variation of mean arterial blood pressure, cardiac sensitivity to baroreflex, and cardiac vagal tone (CVT). Results showed that the strongest parasympathetic response in the Rett’s group was to the 40 Hz vibratory stimulation and with a significant increase in CVT.

    3.3. Category of Neurological Effects—Pain and Vibratory Analgesia Specific

    The pain-reducing effect of vibration is demonstrated in numerous evidence-based research studies [78][94][95][96][97]. Mechanical and acoustic vibrations have been used extensively to address pain and is a treatment technique in orthopedics and low back pain [98][99], physiotherapy [100][101][102], during cosmetic procedures [103], and during orthodontic work and orofacial pain [104][105][106][107]. However, until relatively recently, very little was thoroughly described and understood about pain perception mechanisms. Studies with electrophysiology have shown cortical neurons responding to noxious stimuli, but it has not become clear to what extent this response represents pain or correlates with it [108]. Consequently, the mechanisms by which vibration acts as an analgesic is less understood.

    3.3.1. Basic Mechanism: Gate Control

    One of the submechanisms of the general mechanism of nerve stimulation but a basic mechanism of analgesia is focused on the function of the substantia gelatinosa in the dorsal horn and is commonly known as gate control. The theory for this pain mechanism was proposed by Melzack and Wall [109] and postulates that the substantia gelatinosa modulates sensory information being transmitted to the spinal cord and the brain. Specifically, signals from pain receptors are carried to the dorsal horn by small diameter afferent A-delta and C fibers. The signal transmission from the pain receptors can be modulated (inhibited) by the large afferent A-alpha and A-beta fibers transmitting sensory signals from skin sensation such as touch or vibration [78][96][109]. This mechanism known as gate control theory has been subject of considerable criticism and aspects have been questioned [110][111] and enhanced by Melzack’s neuromatrix of pain theory [112] but its fundamental function remains.
    Salter and Henry [113] specifically explored the response of wide dynamic range (WDR) spinal neurons in the lumbar dorsal horn to vibration at different amplitudes and frequencies to determine how they might play a role in analgesic effects. They tried a variety of frequencies and intensities and found that WDR neurons entrained to the vibratory frequencies below 80 Hz. Their findings suggest that pain reduction is accomplished by the effect of vibration on Pacinian corpuscle afferents and the WDR neuron response in the dorsal horn but that frequency, location, and intensity of the vibratory stimulus is a factor that needs further clarification.

    3.3.2. Basic Mechanism: Modulating Autonomic Responses—Pain and Beyond

    An alternative medical practice that has growing scientific evidence for its effect on the central nervous system and regulating autonomic responses is acupuncture [114]. The clinical efficacy of acupuncture may reside in its neurobiological foundations and in its purported effect of creating biochemical changes in the body and brain that control the autonomic nervous system’s functions such as blood pressure, heart rate variability, skin temperature, and perception of pain. The detailed explanation of mechanisms is still needed.
    One question that arises in relation to acupuncture is whether the specific acupoints must be punctured with needles or whether vibratory sound stimulation might have the same effect. Xu et al. [115] explored this question by looking for microcirculation using laser Doppler flowmetry at meridian acupoints while stimulating the points with low frequency sound waves between 16 and 160 Hz. They found different points respond optimally to different sound frequencies. For example, the point Yin Ling Quan: A0 responded to 29.14 Hz, Zusanli A1 responded best to 58.27 Hz, and Tianjing A2 to 110.00 Hz. Brătilă and Moldovan [116] used an electrical input output model to determine optimal frequencies for the lung meridian (124 Hz) and kidney meridian (120 Hz). Weber et al. [117] explored the use of a simultaneous sound combination (32, 48, and 64 Hz) for its effectiveness to reduce perceived pain intensity and pain threshold compared to a single frequency sound stimulation and a sham. They applied electromagnetic transducers to five acupoints indicated for relief of pain and anxiety and subjected 13 pain-free participants to a cold pressor test. Results showed that both multifrequency and single frequency sound stimulation significantly improved pain tolerance and reduce intensity of pain.

    3.3.3. Basic Mechanism: Neurotransmitters—Pain and Beyond

    Unpacking the complexity of the role of neurotransmitters and neuromodulators on the body and brain is beyond the scope of this paper. However, research has shown instances in which neurotransmitters are stimulated by vibration and these will be described here.
    In relation to vibratory analgesia, Salter and Henry [118] examined specifically the vibratory activation of P1-purinergic receptors in the dorsal horn by the neurotransmitter adenosine. In a study with cats, vibration was applied at 80 Hz in 2.5–3.5 s trains every 20–25 s for 10 min. This resulted in a vibration-induced depression of lower lumbar nociceptive neurons and remained in effect for up to 4 h after the stimulation. Various agents used to attenuate the depression of these neurons revealed that adenosine was responsible for the analgesic effect. The study suggests that the effect earlier described as gate control may be mediated by the release of adenosine resulting from vibration.
    Several neurotransmitters not specifically related to pain have already been discussed in other contexts above. Assuming vibration can stimulate the vagus nerve and the related splenic nerve as discussed above, vibration then has the effect of releasing acetylcholine, which plays a key role in synapses and especially at the location where nerves and muscles connect. It also plays a role in controlling the autonomic nervous system and a particularly important role in the cognitive system and in regulating heart rate. Additionally, stimulation of the splenic nerve causes the induction of norepinephrine. Nitric oxide, extensively discussed above, is also a neurotransmitter serving to regulate and mediate processes of the nervous, immune, and cognitive systems.
    Gamma-aminobutyric acid (GABA) is a prominent neurotransmitter in the brain and the central nervous system. It plays a crucial role reducing the activity of neurons and especially in control of fear and anxiety. Safarov and Kerimov [119][120] in two separate animal studies explored the effect of low frequency vibration (20 Hz) on GABA levels and its metabolism. The found that vibration, regardless of duration, increased GABA level in the brain stem, the large hemispheres, and the cerebellum as well as activity of the glutamate decarboxylase enzyme, which produces GABA. However, they found the effect more marked with 30 min stimulation than with long periods like 7 h. The implication is that one of the mechanisms creating the relaxation effect of vibroacoustic stimulation may be the boost in neurotransmitter GABA.

    3.4. Basic Mechanism: Oscillatory Coherence Supports Connectivity and Circuit Function

    The neurological effect from rhythmically pulsed sensory stimulation is premised on two important postulates: (1) that rhythmic sensory stimulation (RSS) drives a neural response resulting in increased oscillatory coherence and (2) that oscillatory coherence is crucially linked to connectivity, circuit function, and related to health conditions.
    As to the postulation that RSS drives a neural response, recent research in somatosensory, auditory, and visual modalities shows that vibrotactile rhythmically pulsed stimulation has a strong neural driving effect [121][122][123]. For example, vibratory stimulation of a finger, the hand, or the median nerve results in an oscillatory response in primary and secondary sensorimotor cortices [124][125][126] and attention plays almost no role [127]. More auditory rhythmic stimulation research has been done to elicit steady-state or spontaneous oscillatory responses using clicks, amplitude-modulated isochronous sounds [128], or pure tones. Examples include a 40 Hz amplitude modulated tone [129][130], or even the rhythms of binaural beats that are created through binaurally detuned tones [131]. What follows then is the conclusion that RSS can drive oscillatory coherence.
    The assertion that oscillatory coherence is linked to circuit function and related to health conditions is more crucial but less understood. Deep brain stimulation (DBS) research suggests that circuit dysfunction is common to many psychiatric and neurological conditions [132][133]. Basically, the dysregulation of circuits that underlies these conditions stems from a lack of excitation-based coherence, disturbed coherence, or coherence that is overly strong in inappropriate neural populations. Llinas pointed specifically to the recurrent connections between the thalamus and the cortex that have a mechanism function to connect areas of the cortex and control information flow [133][134][135][136][137]. These thalamocortical loops serve communication in the brain similar to what an internet hub does. Llinas further maintained that thalamocortical interconnectivity depends primarily on rhythmic oscillatory activity. Thalamocortical loops function optimally with rhythmic oscillatory activity in the cortex in the gamma band (40 Hz) and in the thalamus in the alpha band (10 Hz). Thalamocortical dysrhythmia (TCD) is characterized by a decrease in alpha band activity (power) with a related increase in theta band activity (4–7 Hz) and a reduction in cortically consistent gamma band activity. TCD appears related to neurological and psychiatric conditions; specifically cognitive, motor, auditory, and mood functions. TCD is linked to conditions including Parkinson’s disease, major depression, neurogenic central pain, tinnitus, and schizophrenia [134].
    Assuming then that vibratory stimulation (RSS) can drive oscillatory coherence and potentially regulate dysrhythmic circuits in the brain, RSS may employ the mechanism of oscillatory coherence and positively affect the health conditions resulting to some extent from these dysrhythmias. The positive response of major depression to RSS may be an indicator of this [89]. The mechanism of driving oscillatory coherence with RSS broadens the focus from the neuroscience of circuit connections (the connectome) to the framework of dynamic brain rhythms related to neural spiking activity (the dynome) [13].

    3.4.1. Application: Neurogenic Pain

    Some mechanism for vibratory analgesia were explained above under gate control. However, there is pain that does not appear to stem from nociception and where the application of vibratory stimulation cannot be affecting only the dorsal horn neurons because the frequency is above the primary response level of Pacinian corpuscles and the rapidly adapting mechanoreception system. Such pain may then be neurogenic, stemming from neural circuit dysrhythmias or disconnections. Hollins et al. [97] explores this and determines that in some cases the vibratory analgesia must stem from cortical dynamics and specifically from an interaction of Brodmann areas 3a and 3b/1. Fallon et al. [138] observed that in Fibromyalgia (FM) patients there was increased theta power in the prefrontal and anterior cingulate cortices consistent with TCD characteristics. This increased frontal theta activity was significantly correlated measured tenderness and tiredness scores. Jensen et al. [139] used brain imaging to examine brain connectivity in FM patients and found less connectivity between the rostral anterior cingulate cortex (rACC) (known to play a role in inhibiting pain) and the hippocampus extending into the part of the brain stem known to modulate pain.
    In this context where FM seems to be related to brain dysregulation and connectivity, where pain appears to be related to brain region interaction, and where there is demonstrated potential for vibration to drive neural coherence, it can be speculated that the positive results from vibratory stimulation on FM patients were due to the mechanism of oscillatory coherence [30][140]. Both studies [30][140] used 40 Hz vibrotactile stimulation of the body, used oscillatory coherence and its relation to connectivity as a premise for effect, but did not establish mechanism with brain imaging. The authors are currently engaged in a study to explore this mechanism.

    3.4.2. Application: Neurodegenerative Conditions

    The specific mechanisms or causes related to neurodegenerative diseases and conditions are not fully understood but one path being explored with some success is that of spontaneous brain oscillation power, synchronization, dysrhythmia, and circuit connectivity.
    Dockstader et al. [141] studied the oscillatory power in various frequency bands in brain regions using magnetoencephalography (MEG) imaging in children who had been treated for brain tumors with cranial radiation therapy (CRT). Children treated with CRT consistently are found to have cognitive deficits in attention, processing speed, and memory. The results showed a clear pattern of gamma deficits with a significantly lower gamma oscillation power in the 60–100 Hz range in the resting state.
    Stam et al. [142] studied Alzheimer’s patients (AD) and healthy controls with full-head MEG with the purpose of investigating linear and non-linear interdependencies in the MEG signal channels. Results showed that this measure of synchronization was lower in AD in the 10–14 Hz alpha band, 18–22 Hz beta band, and in the 22–40 Hz gamma band. Additionally, studying AD patients with MEG, Ribary et al. [136] looked at 40 Hz oscillatory coherence at cortical and subcortical sites associated with the thalamocortical loop. Results showed that although AD patients had similar activity patterns as healthy patients, the AD patients had reduced gamma activity in the cortical component.
    Recent research [42][43][143][144][145] demonstrated that 40Hz auditory, vibrotactile, or visual rhythmic sensory stimulation (RSS) had significantly positive results on AD symptoms. Although none of these studies confirmed the effect on oscillatory coherence in humans, that mechanism can be inferred from the method and results. A possible submechanism of RSS driving oscillatory coherence at 40 Hz was shown by Iaccarino [42]. They demonstrated that in AD mice the effect of the general 40 Hz RSS was to drive fast-spiking parvalbumin-positive-interneurons (at 40 Hz but not at other frequencies) and as a result reducing amyloid-β levels. They also observed a reduction in inflammation, increase in microglia activity, blood vessel lumen size, and cognitive performance.
    Lozano and Lipsman [132] review and explain dysfunctional brain circuits and specifically how deep brain stimulation (DBS) can mitigate the effect, for example, of the motor circuit affecting Parkinson’s disease (PD). The role of DBS in relation to the dysfunctional motor circuit in PD is the inhibition of a group of neurons with 130 Hz electrical stimulation. While the widely accepted approach of DBS is an inhibitory one, Neuman et al. [146] point out that DBS modulates the motor circuit but does not restore it functionally. They differentiate the motor circuit pathways more precisely in the basal ganglia and suggest their work may inspire innovative ways to improve the therapeutic efficacy of neuromodulation in PD. Several studies have used sound vibration as a neuromodulatory stimulant with PD patients [44][147]. One study applied 30 Hz and the other 40 Hz. Both had significant positive results and, although no neuroimaging was used to verify effects on circuit function, they pointed to the potential mechanism of vibration therapy with PD.

    3.4.3. Submechanism: Frontal Oscillatory Symmetry

    The discussion above has already identified a vibration mechanism related to major depressive disorder (MDD) under vagal stimulation and under oscillatory coherence and TCD. Decreased connectivity is a clearly identified factor in MDD [148] and so affecting MDD by driving coherence with rhythmic sound and vibration is a possibility. There is a further potential mechanism for MDD related to frontal asymmetry. There is considerable evidence that frontal EEG asymmetry between left and right in the alpha band is a biomarker for depression and anxiety [149] but age, gender, and severity of depression interaction raises a caution on this [150]. However, studies have shown that using music stimulation with depressed participants has resulted in a reduction of frontal asymmetry in the EEG [151][152][153]. These music studies did not use low frequency sound or vibrotactile stimulation. The only known study that has used vibrotactile gamma stimulation [89] did show significant reduction in depression severity. More research into the occurrence of frontal oscillatory asymmetry and vibratory stimulation is needed.

    The entry is from 10.3390/healthcare9050597

    References

    1. MacDonald, R.; Kreutz, G.; Mitchell, L. What is Music, Health, and Wellbeing and Why is it Important? In Music, Health, and Wellbeing; Oxford University Press: Oxford, UK, 2012; ISBN 9780191738357.
    2. Spintge, R.; Droh, R. Introductory Remarks. In MusicMedicine; MMB Music Inc.: St. Louis, MO, USA, 1992; pp. 1–2.
    3. Maranto, D. Foreword. In The Art & Science of Music Therapy: A Handbook; Wigram, T., Saperston, B., West, R., Eds.; Routledge: New York, NY, USA, 1995; pp. ix–xii.
    4. Dworkin, R.H.; Turk, D.C.; Farrar, J.T.; Haythornthwaite, J.A.; Jensen, M.P.; Katz, N.P.; Kerns, R.D.; Stucki, G.; Allen, R.R.; Bellamy, N.; et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005, 113, 9–19.
    5. Craver, C.; Bechtel, W. Mechanisms and mechanistic explanation. In The Philosophy of Science: An Encyclopedia; Sarkar, S., Pfeifer, J., Eds.; Routledge: New York, NY, USA, 2006; pp. 469–478.
    6. Stegemöller, E. Exploring the Mechanisms of Music Therapy|The Scientist Magazine®. Available online: (accessed on 25 March 2021).
    7. Cheever, T.; Taylor, A.; Finkelstein, R.; Edwards, E.; Thomas, L.; Bradt, J.; Holochwost, S.J.; Johnson, J.K.; Limb, C.; Patel, A.D.; et al. NIH/Kennedy Center Workshop on Music and the Brain: Finding Harmony. Neuron 2018, 97, 1214–1218.
    8. Chanda, M.L.; Levitin, D.J. The neurochemistry of music. Trends Cogn. Sci. 2013, 17, 179–193.
    9. Möckel, M.; Röcker, L.; Störk, T.; Vollert, J.; Danne, O.; Eichstädt, H.; Müller, R.; Hochrein, H. Immediate physiological responses of healthy volunteers to different types of music: Cardiovascular, hormonal and mental changes. Eur. J. Appl. Physiol. Occup. Physiol. 1994, 68, 451–459.
    10. Clements-Cortes, A.; Bartel, L. Are We Doing More Than We Know? Possible Mechanisms of Response to Music Therapy. Front. Med. 2018, 5, 255.
    11. Thaut, M. Neurologic music therapy: From social science to neuroscience. In Handbook of Neurologic Music Therapy; Thaut, M., McIntosh, G., Eds.; Oxford University Press: Oxford, UK, 2014; pp. 1–6.
    12. Altenmüller, E.; Marco-Pallares, J.; Münte, T.F.; Schneider, S. Neural Reorganization Underlies Improvement in Stroke-induced Motor Dysfunction by Music-supported Therapy. Ann. N. Y. Acad. Sci. 2009, 1169, 395–405.
    13. Kopell, N.J.; Gritton, H.J.; Whittington, M.A.; Kramer, M.A. Beyond the connectome: The dynome. Neuron 2014, 83, 1319–1328.
    14. Albouy, P.; Baillet, S.; Zatorre, R.J. Driving working memory with frequency-tuned noninvasive brain stimulation. Ann. N. Y. Acad. Sci. 2018, 1423, 126–137.
    15. Snyder, R. Music and Memory: An Introduction; The MIT Press: Cambridge MA, USA, 2000.
    16. Julien, C. The enigma of Mayer waves: Facts and models. Cardiovasc. Res. 2006, 70, 12–21.
    17. Mansfield, N. Human Response to Vibration; CRC Press: New York, NY, USA, 2005.
    18. Castelo Branco, N.A.A.; Alves-Pereira, M. Vibroacoustic disease. Noise Health 2004, 6, 3–20.
    19. Goetz, C.G. Jean-Martin Charcot and his vibratory chair for Parkinson disease. Neurology 2009, 73, 475–478.
    20. Vibratory Therapeutics. Scientific American; Springer Nature: New York, NY, USA, 1892; p. 265.
    21. Charcot, J.M. Vibratory therapeutics.-The application of rapid and continuous vibrations to the treétment of certain diseases of the nervous system. J. Nerv. Ment. Dis. 2011, 199, 821–827.
    22. Kaeding, T. The Historical Evolution of the Therapeutic Application of Whole Body Vibrations: Any Lessons to be Learned? Austin Sports Med. 2016, 1, 1003. Available online: (accessed on 25 March 2021).
    23. Marín-Cascales, E.; Alcaraz, P.E.; Ramos-Campo, D.J.; Martinez-Rodriguez, A.; Chung, L.H.; Rubio-Arias, J. Whole-body vibration training and bone health in postmenopausal women: A systematic review and meta-analysis. Medicine 2018, 97, e11918.
    24. Del Pozo-Cruz, B.; Adsuar, J.C.; Parraca, J.A.; Del Pozo-Cruz, J.; Olivares, P.R.; Gusi, N. Using whole-body vibration training in patients affected with common neurological diseases: A systematic literature review. J. Altern. Complement. Med. 2012, 18, 29–41.
    25. Wigram, A. The Effect of Vibroacoustic Therapy on Clinical and Non-Clinical Populations. Ph.D. Thesis, London University, London, UK, 1996.
    26. Skille, O. VibroAcoustic Therapy. Music Ther. 1989, 8, 61–77.
    27. Lehikoinen, P. The physioacoustic method. In Music Vibration and Health; Wigram, T., Dileo, C., Eds.; Jeffrey Books: Cherry Hill, NJ, USA, 1997; pp. 209–215.
    28. Campbell, E.A. Vibroacoustic Treatment and Self-Care for Managing the Chronic Pain Experience: An Operational Model. Ph.D. Thesis, University of Jyväskylä, Jyväskylän Yliopisto, Finland, 2019.
    29. Tyack, P.L. Bioacoustics. In Encyclopedia of Ocean Sciences: Second Edition; Elsevier: Amsterdam, The Netherlands, 2001; pp. 357–363. ISBN 9780123744739.
    30. Naghdi, L.; Ahonen, H.; Macario, P.; Bartel, L. The effect of low-frequency sound stimulation on patients with fibromyalgia: A clinical study. Pain Res. Manag. 2015, 20, e21–e27.
    31. Stenfelt, S. Acoustic and physiologic aspects of bone conduction hearing. Adv. Otorhinolaryngol. 2011, 71, 10–21.
    32. Bartel, L.R.; Chen, R.; Alain, C.; Ross, B. Vibroacoustic Stimulation and Brain Oscillation: From Basic Research to Clinical Application. Music Med. 2017, 9, 153–166.
    33. Adams, J.A.; Uryash, A.; Bassuk, J.; Sackner, M.A.; Kurlansky, P. Biological basis of neuroprotection and neurotherapeutic effects of Whole Body Periodic Acceleration (pGz). Med. Hypotheses 2014, 82, 681–687.
    34. Maloney-Hinds, C.; Petrofsky, J.S.; Zimmerman, G.; Hessinger, D.A. The role of nitric oxide in skin blood flow increases due to vibration in healthy adults and adults with type 2 diabetes. Diabetes Technol. Ther. 2009, 11, 39–43.
    35. Johnson, K.O. The roles and functions of cutaneous mechanoreceptors. Curr. Opin. Neurobiol. 2001, 11, 455–461.
    36. Gilman, S. Joint position sense and vibration sense: Anatomical organisation and assessment. J. Neurol. Neurosurg. Psychiatry 2002, 73, 473–477.
    37. Lehikoinen, P. Physioacoustic Sound in Stimulation of Cell Membranes; Next Wave Ltd.: Helsinki, Finland, 1996.
    38. Skille, O.; Wigram, T. The effects of music, vocalization and vibration on brain and muscle tissues: Studies in vibroacoustic therapy. In The Art & Science of Music Therapy: A Handbook; Wigram, T., Saperson, B., West, R., Eds.; Routledge: New York, NY, USA, 1995; pp. 23–57.
    39. Karkkainen, M.; Mitsui, J. The effects of sound based vibration treatment on the human mind and body: The physioacoustic method. J. Int. Soc. Life Inf. Sci. 2006, 24, 155.
    40. Mosabbir, A.; Almeida, Q.J.; Ahonen, H. The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial. Healthcare 2020, 8, 113.
    41. Vuong, V.; Mosabbir, A.; Paneduro, D.; Picard, L.; Faghfoury, H.; Evans, M.; Gordon, A.; Bartel, L. Effects of Rhythmic Sensory Stimulation on Ehlers–Danlos Syndrome: A Pilot Study. Pain Res. Manag. 2020, 2020, 3586767.
    42. Iaccarino, H.F.; Singer, A.C.; Martorell, A.J.; Rudenko, A.; Gao, F.; Gillingham, T.Z.; Mathys, H.; Seo, J.; Kritskiy, O.; Abdurrob, F.; et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 2016, 540, 230–235.
    43. Clements-Cortes, A.; Ahonen, H.; Evans, M.; Freedman, M.; Bartel, L. Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer’s Disease: An Exploratory Pilot Study. J. Alzheimer’s Dis. 2016, 52, 651–660.
    44. King, L.K.; Almeida, Q.J.; Ahonen, H. Short-term effects of vibration therapy on motor impairments in Parkinson’s disease. NeuroRehabilitation 2009, 25, 297–306.
    45. Wysocki, A.; Mary Butler, M.; Shamliyan, T.; Robert Kane, M.L. Whole-Body Vibration Therapy for Osteoporosis. Ann. Intern. Med. 2011, 15, 680–686.
    46. Osteoporosis Prevention Product Wins FDA Breakthrough Device Designation–Bone Health Technologies. Available online: (accessed on 29 April 2021).
    47. FDA Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults|FDA. Available online: (accessed on 29 April 2021).
    48. Sethi, S.; Yin, J.; Anderson, P.K. Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial. Clin. Transl. Med. 2014, 3, 29.
    49. Shipley, T.; Farouk, K.; El-Bialy, T. Effect of high-frequency vibration on orthodontic tooth movement and bone density. J. Orthod. Sci. 2019, 8, 15.
    50. Uryash, A.; Adams, J. Vibroacoustic Noninvasive Stimulation (VATS) of Human Coronary Endothelial Cells Induced Syndecan-4, VEGF and KLF2 Mechanosensor Control of eNOS|Circulation. Circulation 2018, 136, A18011.
    51. Uryash, A.; Adams, J. Wearable Vibroacoustic Transthoracic Stimulation (VATS) Provides Cardioprotection by Syndecan-4 Mechanosensor Regulation of NFAT, JNK/ERK in Rats after Myocardial Infarction|Circulation. Circulation 2018, 136, 17906.
    52. Chen, K.; Pittman, R.N.; Popel, A.S. Nitric oxide in the vasculature: Where does it come from and where does it go? A quantitative perspective. Antioxid. Redox Signal 2008, 10, 1185–1198.
    53. White, C.R.; Haidekker, M.A.; Stevens, H.Y.; Frangos, J.A. Extracellular signal-regulated kinase activation and endothelin-1 production in human endothelial cells exposed to vibration. J. Physiol. 2004, 555, 565–572.
    54. Uryash, A.; Wu, H.; Bassuk, J.; Kurlansky, P.; Sackner, M.A.; Adams, J.A. Low-amplitude pulses to the circulation through periodic acceleration induces endothelial-dependent vasodilatation. J. Appl. Physiol. 2009, 106, 1840–1847.
    55. Ichioka, S.; Yokogawa, H.; Nakagami, G.; Sekiya, N.; Hiromi, S. In vivo analysis of skin microcirculation and the role of nitric oxide during vibration. Ostomy Wound Manag. 2011, 57, 40–47.
    56. Uryash, A.; Adams, J. Wearable Vibroacoustic Transthoracic Stimulation Improves Left Ventricular Function, Remodeling and Regulates Syndecan-4 /VEGF Levels in Rats After Myocardial Infarction|Circulation. Circulation 2018, 134, A17052.
    57. Skoglund, C.R. Vasodilatation in human skin induced by low-amplitude high-frequency vibration. Clin. Physiol. 1989, 9, 361–372.
    58. Johnson, P.K.; Feland, J.B.; Johnson, A.W.; Mack, G.W.; Mitchell, U.H. Effect of whole body vibration on skin blood flow and nitric oxide production. J. Diabetes Sci. Technol. 2014, 8, 889–894.
    59. Adams, J.A.; Bassuk, J.A.; Arias, J.; Wu, H.; Jorapur, V.; Lamas, G.A.; Kurlansky, P. Periodic acceleration (pGz) CPR in a swine model of asphyxia induced cardiac arrest. Short-term hemodynamic comparisons. Resuscitation 2008, 77, 132–138.
    60. Adams, J.A.; Uryash, A.; Wu, H.; Bassuk, J.A.; Nadkarni, V.; Berg, R.; Jorapur, V.; Kurlansky, P. Microcirculatory and therapeutic effects of whole body periodic acceleration (pGz) applied after cardiac arrest in pigs. Resuscitation 2011, 82, 767–775.
    61. Adams, J.A.; Wu, H.; Bassuk, J.A.; Arias, J.; Uryash, A.; Jorapur, V.; Lamas, G.A.; Kurlansky, P. Periodic acceleration (pGz) prior to whole body Ischemia reperfusion injury provides early cardioprotective preconditioning. Life Sci. 2010, 86, 707–715.
    62. Bassuk, J.I.; Wu, H.; Arias, J.; Kurlansky, P.; Adams, J.A. Whole body periodic acceleration (pGz) improves survival and allows for resuscitation in a model of severe hemorrhagic shock in pigs. J. Surg. Res. 2010, 164, e281–e289.
    63. Lopez, J.R.; Uryash, A.; Kolster, J.; Estève, E.; Zhang, R.; Adams, J.A. Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons. Mol. Neurobiol. 2018, 55, 8680–8694.
    64. Martínez, A.; Arias, J.; Bassuk, J.A.; Wu, H.; Kurlansky, P.; Adams, J.A. Adrenomedullin Is Increased by Pulsatile Shear Stress on the Vascular Endothelium via Periodic Acceleration (PGz). Peptides 2008, 29, 73–78.
    65. Uryash, A.; Bassuk, J.; Kurlansky, P.; Altamirano, F.; Lopez, J.R.; Adams, J.A. Antioxidant Properties of Whole Body Periodic Acceleration (pGz). PLoS ONE 2015, 10, e0131392.
    66. Hoffmann, A.; Gill, H. Externally Applied Vibration at 50 Hz Facilitates Dissolution of Blood Clots In-Vitro. Am. J. Biomed. Sci. 2012, 4, 274–284.
    67. Hoffmann, A.; Gill, H. Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis. Thromb. J. 2012, 10, 23.
    68. Faine, B.A.; Dayal, S.; Kumar, R.; Lentz, S.R.; Leira, E.C. Helicopter “Drip and Ship” Flights Do Not Alter the Pharmacological Integrity of rtPA. J. Stroke Cerebrovasc. Dis. 2018, 27, 2720–2724.
    69. Leira, E.C.; Zaheer, A.; Schnell, T.; Torner, J.C.; Olalde, H.M.; Pieper, A.A.; Ortega-Gutierrez, S.; Nagaraja, N.; Marks, N.L.; Adams, H.P. Effect of helicopter transport on neurological outcomes in a mouse model of embolic stroke with reperfusion: AIR-MICE pilot study. Int. J. Stroke 2015, 10, 119–124.
    70. Dhanesha, N.; Schnell, T.; Rahmatalla, S.; Deshaw, J.; Thedens, D.; Parker, B.M.; Zimmerman, M.B.; Pieper, A.A.; Chauhan, A.K.; Leira, E.C. Low-Frequency Vibrations Enhance Thrombolytic Therapy and Improve Stroke Outcomes. Stroke 2020, 51, 1855–1861.
    71. Kawamura, K.; Kano, Y. Electrical stimulation induces neurite outgrowth in PC12m3 cells via the p38 mitogen-activated protein kinase pathway. Neurosci. Lett. 2019, 698, 81–84.
    72. Koike, Y.; iwamoto, S.; kimata, Y.; nohno, T.; hiragami, F.; kawamura, K.; numata, K.; Murai, H.; Okisima, K.; Iwata, M.; et al. Low-frequency vibratory sound induces neurite outgrowth in pc12m3 cells in which nerve growth factor-induced neurite outgrowth is impaired. Tissue Cult. Res. Commun. 2004, 23, 81–90.
    73. Cho, H.; Seo, Y.K.; Jeon, S.; Yoon, H.H.; Choi, Y.K.; Park, J.K. Neural differentiation of umbilical cord mesenchymal stem cells by sub-sonic vibration. Life Sci. 2012, 90, 591–599.
    74. Kim, H.J.; Kim, J.H.; Song, Y.J.; Seo, Y.K.; Park, J.K.; Kim, C.W. Overexpressed Calponin3 by Subsonic Vibration Induces Neural Differentiation of hUC-MSCs by Regulating the Ionotropic Glutamate Receptor. Appl. Biochem. Biotechnol. 2015, 177, 48–62.
    75. Choi, Y.K.; Cho, H.; Seo, Y.K.; Yoon, H.H.; Park, J.K. Stimulation of sub-sonic vibration promotes the differentiation of adipose tissue-derived mesenchymal stem cells into neural cells. Life Sci. 2012, 91, 329–337.
    76. Kantor, J.; Kantorová, L.; Marečková, J.; Peng, D.; Vilímek, Z. Potential of vibroacoustic therapy in persons with cerebral palsy: An advanced narrative review. Int. J. Environ. Res. Public Health 2019, 16, 3940.
    77. Kantele, S.; Karinkanta, S.; Sievänen, H. Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials. J. Neurol. Sci. 2015, 358, 31–37.
    78. Lundeberg, T.; Nordemar, R.; Ottoson, D. Pain alleviation by vibratory stimulation. Pain 1984, 20, 25–44.
    79. Usoskin, D.; Zilberter, M.; Linnarsson, S.; Hjerling-Leffler, J.; Uhlén, P.; Harkany, T.; Ernfors, P. En masse in vitro functional profiling of the axonal mechanosensitivity of sensory neurons. Proc. Natl. Acad. Sci. USA 2010, 107, 16336–16341.
    80. Katusic, A.; Alimovic, S.; Mejaski-Bosnjak, V. The effect of vibration therapy on spasticity and motor function in children with cerebral palsy: A randomized controlled trial. NeuroRehabilitation 2013, 32, 1–8.
    81. Gay, A.; Parratte, S.; Salazard, B.; Guinard, D.; Pham, T.; Legré, R.; Roll, J.P. Proprioceptive feedback enhancement induced by vibratory stimulation in complex regional pain syndrome type I: An open comparative pilot study in 11 patients. Jt. Bone Spine 2007, 74, 461–466.
    82. Delecluse, C.; Roelants, M.; Verschueren, S. Strength Increase after Whole-Body Vibration Compared with Resistance Training. Med. Sci. Sport. Exerc. 2003, 35, 1033–1041.
    83. Ko, M.S.; Sim, Y.J.; Kim, D.H.; Jeon, H.S. Effects of three weeks of whole-body vibration training on joint-position sense, balance, and gait in children with cerebral palsy: A randomized controlled study. Physiother. Can. 2016, 68, 99–105.
    84. Howland, R.H. Vagus Nerve Stimulation. Curr. Behav. Neurosci. Rep. 2014, 1, 64–73.
    85. Huston, J.M.; Ochani, M.; Rosas-Ballina, M.; Liao, H.; Ochani, K.; Pavlov, V.A.; Gallowitsch-Puerta, M.; Ashok, M.; Czura, C.J.; Foxwell, B.; et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 2006, 203, 1623–1629.
    86. Vida, G.; Peña, G.; Deitch, E.A.; Ulloa, L. α7-Cholinergic Receptor Mediates Vagal Induction of Splenic Norepinephrine. J. Immunol. 2011, 186, 4340–4346.
    87. Simon, T.; Panzolini, C.; Lavergne, J.; Srihar, A.; Vervoordeldonk, M.; Glaichenhaus, N.; Blancou, P. Stimulation of Splenic Neurovascular Bundle Protect Mice from Developing Collagen-induced Arthritis-ACR Meeting Abstracts. In Proceedings of the 2019 ACR/ARP Annual Meeting, Atlanta, GA, USA, 13 November 2019.
    88. Sigurdardóttir, G.A.; Nielsen, P.M.; Rønager, J.; Wang, A.G. A pilot study on high amplitude low frequency–music impulse stimulation as an add-on treatment for depression. Brain Behav. 2019, 9, e01399.
    89. Braun Janzen, T.; Al Shirawi, M.I.; Rotzinger, S.; Kennedy, S.H.; Bartel, L. A Pilot Study Investigating the Effect of Music-Based Intervention on Depression and Anhedonia. Front. Psychol. 2019, 10, 1038.
    90. Julu, P.O.O.; Kerr, A.M.; Hansen, S.; Apartopoulos, F.; Jamal, G.A. Functional evidence of brain stem immaturity in Rett syndrome. Eur. Child Adolesc. Psychiatry 1997, 6, 47–54.
    91. Wilfong, A.A.; Schultz, R.J. Vagus nerve stimulation for treatment of epilepsy in Rett syndrome. Dev. Med. Child Neurol. 2007, 48, 683–686.
    92. Adcock, K.S.; Chandler, C.; Buell, E.P.; Solorzano, B.R.; Loerwald, K.W.; Borland, M.S.; Engineer, C.T. Vagus nerve stimulation paired with tones restores auditory processing in a rat model of Rett syndrome. Brain Stimul. 2020, 13, 1494–1503.
    93. Bergström-Isacsson, M.; Lagerkvist, B.; Holck, U.; Gold, C. Neurophysiological responses to music and vibroacoustic stimuli in Rett syndrome. Res. Dev. Disabil. 2014, 35, 1281–1291.
    94. Zoppi, M.; Voegelin, M.R.; Signorini, M.; Zamponi, A. Pain threshold changes by skin vibratory stimulation in healthy subjects. Acta Physiol. Scand. 1991, 143, 439–444.
    95. Hollins, M.; Roy, E.A.; Crane, S.A. Vibratory antinociception: Effects of vibration amplitude and frequency. J. Pain 2003, 4, 381–391.
    96. Kakigi, R.; Shibasaki, H. Mechanisms of pain relief by vibration and movement. J. Neurol. Neurosurg. Psychiatry 1992, 55, 282–286.
    97. Hollins, M.; McDermott, K.; Harper, D. How does vibration reduce pain? Perception 2014, 43, 70–84.
    98. Cerciello, S.; Rossi, S.; Visonà, E.; Corona, K.; Oliva, F. Clinical applications of vibration therapy in orthopaedic practice. Muscles. Ligaments Tendons J. 2016, 6, 147–156.
    99. Lurie, R.C.; Cimino, S.R.; Gregory, D.E.; Brown, S.H.M. The effect of short duration low back vibration on pain developed during prolonged standing. Appl. Ergon. 2018, 67, 246–251.
    100. Cochrane, D.J. Effectiveness of using wearable vibration therapy to alleviate muscle soreness. Eur. J. Appl. Physiol. 2017, 117, 501–509.
    101. Veqar, Z.; Imtiyaz, S. Vibration Therapy in Management of Delayed Onset Muscle Soreness (DOMS). J. Clin. Diagn. Res. 2014, 8, LE01–LE04.
    102. Muceli, S.; Farina, D.; Kirkesola, G.; Katch, F.; Falla, D. Reduced force steadiness in women with neck pain and the effect of short term vibration. J. Electromyogr. Kinesiol. 2011, 21, 283–290.
    103. Sharma, P.; Czyz, C.N.; Wulc, A.E. Investigating the Efficacy of Vibration Anesthesia to Reduce Pain from Cosmetic Botulinum Toxin Injections. Aesthetic Surg. J. 2011, 31, 966–971.
    104. Hansson, P.; Ekblom, A. Afferent stimulation induced pain relief in acute oro-facial pain and its failure to induce sufficient pain reduction in dental and oral surgery. Pain 1984, 20, 273–278.
    105. Lobre, W.D.; Callegari, B.J.; Gardner, G.; Marsh, C.M.; Bush, A.C.; Dunn, W.J. Pain control in orthodontics using a micropulse vibration device: A randomized clinical trial. Angle Orthod. 2016, 86, 625–630.
    106. Jing, D.; Xiao, J.; Li, X.; Li, Y.; Zhao, Z. The effectiveness of vibrational stimulus to accelerate orthodontic tooth movement: A systematic review. BMC Oral Health 2017, 17, 143.
    107. Roy, E.A.; Hollins, M.; Maixner, W. Reduction of TMD pain by high-frequency vibration: A spatial and temporal analysis. Pain 2003, 101, 267–274.
    108. National Research Council (US) Committee on Recognition and Alleviation of Pain in Laboratory Animals. Chapter 2 Mechanisms of Pain. In Recognition and Alleviation of Pain in Laboratory Animals; National Academies Press: Washington, DC, USA, 2009. Available online: (accessed on 26 March 2021).
    109. Melzack, R.; Wall, P.D. Pain mechanisms: A new theory. Science 1965, 150, 971–979.
    110. Moayedi, M.; Davis, K.D. Theories of pain: From specificity to gate control. J. Neurophysiol. 2013, 109, 5–12.
    111. Mendell, L.M. Constructing and deconstructing the gate theory of pain. Pain 2014, 155, 210–216.
    112. Melzack, R. Pain and the neuromatrix in the brain. J. Dent. Educ. 2001, 65, 1378–1382.
    113. Salter, M.W.; Henry, J.L. Physiological characteristics of responses of wide dynamic range spinal neurones to cutaneously applied vibration in the cat. Brain Res. 1990, 507, 69–84.
    114. Li, Q.Q.; Shi, G.X.; Xu, Q.; Wang, J.; Liu, C.Z.; Wang, L.P. Acupuncture effect and central autonomic regulation. Evid. Based Complement. Altern. Med. 2013, 2013, 267959.
    115. Xu, J.; Tany, X.; Guo, Y. Effect of somatosensory music low frequency acoustic wave on 12 main and collateral channels and acupuncture point microcirculation on 30 cases of healthy people. JCAM 2014, 30, 8–14.
    116. Bratila, F.; Moldovan, F. Music acupuncture stimulation method-PubMed. Rom. J. Intern. Med. 2007, 45, 407–411.
    117. Weber, A.; Busbridge, S.; Governo, R. Evaluation of the Efficacy of Musical Vibroacupuncture in Pain Relief: A Randomized Controlled Pilot Study. Neuromodul. Technol. Neural Interface 2020, ner.13281.
    118. Salter, M.W.; Henry, J.L. Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat. Neuroscience 1987, 22, 631–650.
    119. Safarov, M.; Kerimov, S. The effect of low-frequency vibration on GABA metabolism in brain structures. Fiziol. Zhurnal 1991, 37, 3–7.
    120. Kerimov, S.; Safarov, M. Effect of vibration on gamma-aminobutyric acid metabolism in the brain in various functional conditions of the adrenal cortex. Fiziol. Zhurnal 1992, 38, 3–7.
    121. Jamali, S.; Ross, B. Somatotopic finger mapping using MEG: Toward an optimal stimulation paradigm. Clin. Neurophysiol. 2013, 124, 1659–1670.
    122. Jamali, S.; Fujioka, T.; Ross, B. Neuromagnetic beta and gamma oscillations in the somatosensory cortex after music training in healthy older adults and a chronic stroke patient. Clin. Neurophysiol. 2014, 125, 1213–1222.
    123. Ross, B.; Jamali, S.; Miyazaki, T.; Fujioka, T. Synchronization of beta and gamma oscillations in the somatosensory evoked neuromagnetic steady-state response in the somatosensory system around 20 Hz. Exp. Neurol. 2013, 245, 40–51.
    124. Bartel, L. Low frequency sound therapy. In International Dictionary of Music Therapy; Routledge: New York, NY, USA, 2013.
    125. Mauguière, F.; Merlet, I.; Forss, N.; Vanni, S.; Jousmäki, V.; Adeleine, P.; Hari, R. Activation of a distributed somatosensory cortical network in the human brain: A dipole modelling study of magnetic fields evoked by median nerve stimulation. Part II: Effects of stimulus rate, attention and stimulus detection. Electroencephalogr. Clin. Neurophysiol. Evoked Potentials 1997, 104, 290–295.
    126. Mauguière, F.; Merlet, I.; Forss, N.; Vanni, S.; Jousmäki, V.; Adeleine, P.; Hari, R. Activation of a distributed somatosensory cortical network in the human brain. A dipole modelling study of magnetic fields evoked by median nerve stimulation. Part I: Location and activation timing of SEF sources. Electroencephalogr. Clin. Neurophysiol. Evoked Potentials 1997, 104, 281–289.
    127. Bardouille, T.; Picton, T.W.; Ross, B. Attention modulates beta oscillations during prolonged tactile stimulation. Eur. J. Neurosci. 2010, 31, 761–769.
    128. Patel, A. A new approach to the cognitive neuroscience of melody. In The Cognitive Neuroscience of Music; Oxford University Press: Oxford, UK, 2012; pp. 1–466. ISBN 9780191689314.
    129. Ross, B.; Herdman, A.T.; Pantev, C. Stimulus Induced Desynchronization of Human Auditory 40-Hz Steady-State Responses. J. Neurophysiol. 2005, 94, 4082–4093.
    130. Pastor, M.A.; Artieda, J.; Arbizu, J.; Marti-Climent, J.M.; Pañuelas, I.; Masdeu, J.C. Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz. J. Neurosci. 2002, 22, 10501–10506.
    131. Miyazaki, T.; Thompson, J.; Fujioka, T.; Ross, B. Sound envelope encoding in the auditory cortex revealed by neuromagnetic responses in the theta to gamma frequency bands. Brain Res. 2013, 1506, 64–75.
    132. Lozano, A.M.; Lipsman, N. Probing and Regulating Dysfunctional Circuits Using Deep Brain Stimulation. Neuron 2013, 77, 406–424.
    133. Llinás, R.; Ribary, U.; Jeanmonod, D.; Cancro, R.; Kronberg, E.; Schulman, J.; Zonenshayn, M.; Magnin, M.; Morel, A.; Siegmund, M. Thalamocortical dysrhythmia I. Functional and imaging aspects. Thalamus Relat. Syst. 2001.
    134. Llinas, R.R.; Ribary, U.; Jeanmonod, D.; Kronberg, E.; Mitra, P.P. Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc. Natl. Acad. Sci. USA 1999, 96, 15222–15227.
    135. Llinas, R.; Ribary, U. Coherent 40-Hz oscillation characterizes dream state in humans. Proc. Natl. Acad. Sci. USA 1993, 90, 2078–2081.
    136. Ribary, U.; Ioannides, A.A.; Singh, K.D.; Hasson, R.; Bolton, J.P.R.; Lado, F.; Mogilner, A.; Llinás, R. Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. Proc. Natl. Acad. Sci. USA 1991, 88, 11037–11041.
    137. Llinás, R.; Urbano, F.J.; Leznik, E.; Ramírez, R.R.; Van Marle, H.J.F. Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci. 2005, 28, 325–333.
    138. Fallon, N.; Chiu, Y.; Nurmikko, T.; Stancak, A. Altered theta oscillations in resting EEG of fibromyalgia syndrome patients. Eur. J. Pain 2018, 22, 49–57.
    139. Jensen, K.B.; Loitoile, R.; Kosek, E.; Petzke, F.; Carville, S.; Fransson, P.; Marcus, H.; Williams, S.C.R.; Choy, E.; Mainguy, Y.; et al. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol. Pain 2012, 8, 32.
    140. Braun Janzen, T.; Paneduro, D.; Picard, L.; Gordon, A.; Bartel, L.R. A parallel randomized controlled trial examining the effects of rhythmic sensory stimulation on fibromyalgia symptoms. PLoS ONE 2019, 14, e0212021.
    141. Dockstader, C.; Wang, F.; Bouffet, E.; Mabbott, D.J. Gamma deficits as a neural signature of cognitive impairment in children treated for brain tumors. J. Neurosci. 2014, 34, 8813–8824.
    142. Stam, C.J.; Van Cappellen van Walsum, A.M.; Pijnenburg, Y.A.L.; Berendse, H.W.; De Munck, J.C.; Scheltens, P.; Van Dijk, B.W. Generalized synchronization of MEG recordings in Alzheimer’s disease: Evidence for involvement of the gamma band. J. Clin. Neurophysiol. 2002, 19, 562–574.
    143. Martorell, A.J.; Paulson, A.L.; Suk, H.J.; Abdurrob, F.; Drummond, G.T.; Guan, W.; Young, J.Z.; Kim, D.N.W.; Kritskiy, O.; Barker, S.J.; et al. Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition. Cell 2019, 177, 256–271.e22.
    144. Wilson, C. Can Listening to a Low Hum Destroy Alzheimer’s Brain Plaques?|New Scientist. Available online: (accessed on 26 March 2021).
    145. Weaver, C. Brain-Wave Treatment for Alzheimer’s Is Promising, but the First Human Subject Is Left Behind|Salon.com. Available online: (accessed on 26 March 2021).
    146. Neumann, W.J.; Schroll, H.; De Almeida Marcelino, A.L.; Horn, A.; Ewert, S.; Irmen, F.; Krause, P.; Schneider, G.H.; Hamker, F.; Kühn, A.A. Functional segregation of basal ganglia pathways in Parkinson’s disease. Brain 2018, 141, 2655–2669.
    147. Desmoulin, G.T.; Szostek, J.S.; Khan, A.H.; Al-Ameri, O.S.; Hunter, C.J.; Bogduk, N. Spinal intervention efficacy on correcting cervical vertebral axes of rotation and the resulting improvements in pain, disability and psychsocial measures. J. Musculoskelet. Pain 2012, 20, 31–40.
    148. Susan Rotzinger, B.; Kennedy, S.; Lam, R.W.; Kennedy, S.H.; Beaulieu, S.; Montréal Glenda MacQueen, F.; Calgary Diane McIntosh, F.; Vancouver Arun Ravindran, F.V.; Toronto, F. The Canadian Biomarker Integration Network for Depression (CAN-BIND): Looking Deeper into Major Depressive Disorder; CANMAT: Toronto, ON, Canada, 2019.
    149. Smit, D.J.A.; Posthuma, D.; Boomsma, D.I.; De Geus, E.J.C. The relation between frontal EEG asymmetry and the risk for anxiety and depression. Biol. Psychol. 2007, 74, 26–33.
    150. van der Vinne, N.; Vollebregt, M.A.; van Putten, M.J.A.M.; Arns, M. Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A meta-analysis. NeuroImage Clin. 2017, 16, 79–87.
    151. Field, T.; Martinez, A.; Nawrocki, T.; Pickens, J.; Fox, N.; Schanberg, S. Music shifts frontal EEG in depressed adolescents. Clin. Trial 1998, 33, 109–116.
    152. Jones, N.A.; Field, T. Massage and music therapies attenuate frontal EEG asymmetry in depressed adolescents. Adolescence 1999, 34, 529–534.
    153. Petchkovsky, L.; Robertson-Gillam, K.; Kropotov, J.; Petchkovsky, M. Using QEEG parameters (asymmetry, coherence, and P3a novelty response) to track improvement in depression after choir therapy. Adv. Ment. Health 2013, 11, 257–267.
    More